Literature DB >> 11250102

Inulin glasses for the stabilization of therapeutic proteins.

W L Hinrichs1, M G Prinsen, H W Frijlink.   

Abstract

Sugar glasses are widely used to stabilize proteins during drying and subsequent storage. To act successfully as a protectant, the sugars should have a high glass transition temperature (Tg), a poor hygroscopicity, a low crystallization rate, and contain no reducing groups. When freeze drying is envisaged as method of drying, a relatively high Tg of the freeze concentrated fraction (Tg') is preferrable. In this study, whether inulins meet these requirements was investigated. Inulins of various degrees of polymerisation (DP) were evaluated. Trehalose glass was used as a positive control. It was found that the Tg and the Tg' of inulins with a number/weight average DP (DP(n)/DP(w)) higher than 5.5/6.0 were higher than those of trehalose glass. Furthermore, inulin glasses showed a similar hygroscopicity to that of trehalose glass but crystallized less rapidly. Less than 6% of the sugar units of inulins with a DP(n)/DP(w) higher than 5.5/6.0 contained reducing groups. Trehalose contained no reducing groups. Freeze drying of an alkaline phosphatase solution without protectant induced an almost complete loss of the activity of the protein. In contrast, when inulins with a DP(n)/DP(w) higher than 5.5/6.0 or trehalose were used as stabilizer, the activity was fully maintained, also after subsequent storage for 4 weeks at 20 degrees C and 0, 45, or 60% RH, respectively. The stabilizing capacities of inulin with a lower DP and glucose were substantially less pronounced. After storage at 60 degrees C for 6 days, the activity of freeze dried samples containing inulins with a DP(n)/DP(w) higher than 5.5/6.0 was still about 50% whereas the activity of samples containing inulin with a lower DP, glucose, or trehalose was completely lost. It is concluded that inulins with a DP(n)/DP(w) higher than 5.5/6.0 meet the physico-chemical characteristics to successfully act as protectants for proteins. The stabilizing potential of these inulins was clearly shown using alkaline phosphatase as a model protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11250102     DOI: 10.1016/s0378-5173(00)00677-3

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  18 in total

1.  Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

2.  Functional analysis of the binding model of microbial inulinases using docking and molecular dynamics simulation.

Authors:  Puneet Kumar Singh; Josmi Joseph; Sukriti Goyal; Abhinav Grover; Pratyoosh Shukla
Journal:  J Mol Model       Date:  2016-03-08       Impact factor: 1.810

3.  Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.

Authors:  Leonard Y Chu; Ling Ye; Ke Dong; Richard W Compans; Chinglai Yang; Mark R Prausnitz
Journal:  Pharm Res       Date:  2015-12-01       Impact factor: 4.200

4.  Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy.

Authors:  Thomas Barclay; Milena Ginic-Markovic; Martin R Johnston; Peter D Cooper; Nikolai Petrovsky
Journal:  Carbohydr Res       Date:  2012-03-10       Impact factor: 2.104

5.  Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.

Authors:  Felix Geeraedts; Vinay Saluja; Wouter ter Veer; Jean-Pierre Amorij; Henderik W Frijlink; Jan Wilschut; Wouter L J Hinrichs; Anke Huckriede
Journal:  AAPS J       Date:  2010-03-02       Impact factor: 4.009

6.  Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers.

Authors:  Jonas H C Eriksson; Wouter L J Hinrichs; Gerhardus J de Jong; Govert W Somsen; Henderik W Frijlink
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

7.  The effect of fructan on membrane lipid organization and dynamics in the dry state.

Authors:  Ingrid J Vereyken; Vladimir Chupin; Folkert A Hoekstra; Sjef C M Smeekens; Ben de Kruijff
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

Review 8.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

9.  Characterization of a cyclosporine solid dispersion for inhalation.

Authors:  Gerrit S Zijlstra; Michiel Rijkeboer; Dirk Jan van Drooge; Marc Sutter; Wim Jiskoot; Marco van de Weert; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  AAPS J       Date:  2007-06-15       Impact factor: 4.009

Review 10.  Fructan and its relationship to abiotic stress tolerance in plants.

Authors:  David P Livingston; Dirk K Hincha; Arnd G Heyer
Journal:  Cell Mol Life Sci       Date:  2009-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.